The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial
(Hinzugefügt: 20.01.2021 um 09:03 Uhr)
A systematic review of experimental evidence for antiviral effects of ivermectin and an in‐silico analysis of ivermectin's possible mode of action against SARS‐CoV‐2
(Hinzugefügt: 14.01.2021 um 08:52 Uhr)
Ivermectin reduces the risk of death from COVID-19 -a rapid review and meta-analysis in support of the recommendation of the Front Line COVID-19 Critical Care Alliance.
(Hinzugefügt: 05.01.2021 um 17:52 Uhr)